ALEXANDRIA MILLER: Open Payments
NPI 1326721648 · FOUNTAIN VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 49 payments from 9 companies in 2025. Trend: 2023 $83 · 2024 $600 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $305 |
| Novartis Pharmaceuticals Corporation | 13 | $191 |
| Amgen Inc. | 6 | $155 |
| Lilly USA, LLC | 5 | $114 |
| SCPHARMACEUTICALS INC. | 3 | $77 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| PFIZER INC. | 1 | $24 |
Products named: JARDIANCE, LEQVIO, REPATHA, FUROSCIX, AMYVID, ELIQUIS, CAMZYOS, VERQUVO.
Industry payments across CA — which companies pay providers there.
